Big Pharma, developmental biology
Pharma Puts Up Money for Biotech
Jef Akst | Mar 21, 2012
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
Opinion: A Big Pharma Biotech Fund
Mark Kessel | Mar 5, 2012
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
How to Make Eyeball Stew
Hannah Waters | Mar 1, 2012
Editor's choice in developmental biology
Model Citizen
Karen Hopkin | Mar 1, 2012
With an eye to understanding animal regeneration, Alejandro Sánchez Alvarado has turned a freshwater planarian into a model system to watch.
How Tigers Get Their Stripes
Bob Grant | Feb 22, 2012
For the first time researchers have demonstrated the molecular tango that gives rise to repeating patterns in developing animal embryos.
Cell Change Up
Cristina Luiggi | Feb 9, 2012
Imaging cell cytoskeletons during early embryonic development leads researchers to uncover a new regulator of cell shape
$785 Million for Tropical Diseases
Hannah Waters | Jan 31, 2012
A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.
Iron Builds a Better Brain
Ruth Williams | Jan 9, 2012
Brain imaging and gene analyses in twins reveal that white matter integrity is linked to an iron homeostasis gene.
FDA Drafts Pharma Social Media Advice
Tia Ghose | Jan 3, 2012
The agency releases draft guidelines on unsolicited questions about off-label use, but leaves many questions about social media marketing unanswered.
Lynne-Marie Postovit: Cancer Modeler
Sabrina Richards | Jan 1, 2012
Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34